Sponsorizzato
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posted
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Cerca
Categorie
- National
- International
- Business
- Technology
- Health
- Formazione
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leggi tutto
Gold prices stable, silver down
KATHMANDU: The price of gold has remained unchanged on Tuesday. According to the Federation of...
Latest WTC standings after ENG vs IND, WI vs AUS Test matches
Australia swept West Indies in a dominant series win. Mitchell Starc and Scott Boland shone for...
Sun directly over Kaaba today: What it means and how to see it
Today at 12:27 PM Mecca time, the sun will be directly above the Kaaba, causing no shadows to...
UAE: Who’s behind Dubai’s massive 300,000-tree plantation project and how much did it really cost?
Who makes a desert bloom, and at what cost? Dubai’s latest greening spree planted 300,000...